LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (drug combination treatments). Dataset 1 of 2: Cell count and normalized growth rate inhibition values. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (drug combination treatments). Dataset 1 of 2: Cell count and normalized growth rate inhibition values. - Dataset (ID:20259)

Filter results: >>>>

Cell	Small Molecule	Small Mol 1 Concentration	Small Mol 1 Conc Unit	Small Molecule 2	Small Mol 2 Concentration	Small Mol 2 Conc Unit	Biological Replicate	Technical Replicate	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Normalized Growth Rate Inhibition Value
BT-20	Alpelisib	0.1235	uM	Neratinib	0.3704	uM	2	3	1843	3167	5162	0.4394
BT-20	Dactolisib	0.0047	uM	Lapatinib	10	uM	2	3	1843	2856	5162	0.3426
BT-20	Alpelisib	0.1235	uM	Selumetinib	10	uM	2	3	1843	3574	5162	0.5614
BT-20	Alpelisib	1.9245	uM		0	uM	2	3	1843	2136	5162	0.1041
BT-20	Alpelisib	0.1235	uM	Neratinib	0.6415	uM	2	3	1843	3357	5162	0.4969